HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angela Migliorini Selected Research

Coronary Artery Disease (Coronary Atherosclerosis)

1/2022Outcomes of Left Main Revascularization after Percutaneous Intervention or Bypass Surgery.
1/2018Old and New NICE Guidelines for the Evaluation of New Onset Stable Chest Pain: A Real World Perspective.
7/2017Angiographic and clinical outcome after crush of everolimus-eluting stent for distal unprotected left main disease.
1/2016Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity.
1/2016Reply: Optimal Medical Therapy in the Prognosis of Coronary Artery Disease.
10/2014Switching from clopidogrel to prasugrel in patients having coronary stent implantation.
6/2014Comparison of double (360 mg) ticagrelor loading dose with standard (60 mg) prasugrel loading dose in ST-elevation myocardial infarction patients: the Rapid Activity of Platelet Inhibitor Drugs (RAPID) primary PCI 2 study.
12/2013Comparison of the degree of platelet aggregation inhibition with prasugrel versus clopidogrel and clinical outcomes in patients with unprotected left main disease treated with everolimus-eluting stents.
4/2013Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study.
10/2012Clinical and angiographic outcomes of patients treated with everolimus-eluting stents or first-generation Paclitaxel-eluting stents for unprotected left main disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Angela Migliorini Research Topics

Disease

45Myocardial Infarction
01/2021 - 05/2002
27Infarction (Infarctions)
01/2016 - 08/2002
24Thrombosis (Thrombus)
01/2023 - 06/2007
19ST Elevation Myocardial Infarction
01/2023 - 04/2005
14Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 08/2006
14Cardiogenic Shock
01/2021 - 06/2002
13Hemorrhage
01/2023 - 08/2002
13Acute Coronary Syndrome
11/2020 - 09/2011
8Stroke (Strokes)
10/2019 - 02/2008
8Death (Near-Death Experience)
12/2018 - 12/2009
6Cardiovascular Diseases (Cardiovascular Disease)
12/2018 - 04/2004
4Ventricular Remodeling
01/2016 - 04/2005
4Heart Failure
05/2013 - 03/2007
3Left Ventricular Dysfunction
08/2017 - 04/2005
3Coronary Disease (Coronary Heart Disease)
03/2017 - 04/2010
3Diabetes Mellitus
03/2017 - 05/2004
1Aortic Valve Stenosis (Aortic Stenosis)
08/2021
1Thromboembolism
08/2019
1Poisoning
08/2019
1Reperfusion Injury
08/2017
1Chronic Renal Insufficiency
03/2017
1Rupture
12/2015
1Inflammation (Inflammations)
07/2015
1Bundle-Branch Block (Fascicular Block)
07/2015
1Hyperplasia
12/2014
1Non-ST Elevated Myocardial Infarction
12/2014
1Chronic Kidney Failure (Chronic Renal Failure)
10/2014
1Ischemia
05/2014
1Hypertension (High Blood Pressure)
12/2013
1Dyslipidemias (Dyslipidemia)
08/2013
1Acute Kidney Injury (Acute Renal Failure)
05/2013
1Neoplasms (Cancer)
01/2012
1Pulmonary Embolism
01/2012
1Body Weight (Weight, Body)
01/2012
1Ischemic Stroke
01/2012
1Coronary Occlusion
03/2006
1Unstable Angina
10/2005

Drug/Important Bio-Agent (IBA)

13Clopidogrel (Plavix)FDA Link
10/2018 - 08/2005
12Abciximab (ReoPro)FDA Link
01/2016 - 08/2002
11Prasugrel HydrochlorideFDA Link
01/2020 - 01/2012
9Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
07/2014 - 07/2004
7omega-Chloroacetophenone (Mace)IBA
12/2018 - 03/2006
5TicagrelorIBA
01/2020 - 04/2013
5EverolimusFDA Link
07/2017 - 10/2012
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2016 - 08/2008
5Creatine Kinase (Creatine Phosphokinase)IBA
05/2012 - 04/2005
3Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2015 - 04/2013
3bivalirudin (Angiomax)FDA Link
06/2014 - 04/2010
2cangrelorIBA
01/2023 - 07/2022
2Doxycycline (Periostat)FDA LinkGeneric
08/2017 - 07/2014
2Insulin (Novolin)FDA Link
03/2017 - 05/2004
2Morphine (MS Contin)FDA LinkGeneric
10/2016 - 01/2015
2Pemetrexed (MTA)FDA Link
01/2016 - 06/2013
2Biomarkers (Surrogate Marker)IBA
07/2015 - 10/2010
2Platelet Membrane Glycoprotein IIbIBA
05/2014 - 02/2007
2Paclitaxel (Taxol)FDA LinkGeneric
10/2012 - 06/2007
2Heparin (Liquaemin)FDA LinkGeneric
11/2010 - 04/2010
2Protamines (Protamine Sulfate)FDA Link
11/2010 - 04/2010
2Sirolimus (Rapamycin)FDA Link
06/2007 - 10/2005
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
11/2020
1Carbon MonoxideIBA
08/2019
1GelatinasesIBA
01/2019
1Adenosine Diphosphate (ADP)IBA
10/2018
1CalciumIBA
01/2018
1ConnectinIBA
08/2017
1Metalloproteases (Metalloproteinases)IBA
08/2017
1Technetium-99IBA
03/2015
1TabletsIBA
02/2015
1TroponinIBA
12/2014
1zotarolimusIBA
12/2014
1Troponin IIBA
05/2013
1CarbonIBA
12/2010
1MetalsIBA
02/2008
1Glycoproteins (Glycoprotein)IBA
02/2007
1Ticlopidine (Ticlid)FDA LinkGeneric
08/2005
1Brain Natriuretic Peptide (Natrecor)FDA Link
04/2005

Therapy/Procedure

38Percutaneous Coronary Intervention
01/2023 - 08/2003
30Stents
01/2023 - 08/2002
17Therapeutics
07/2022 - 08/2002
9Drug-Eluting Stents
12/2018 - 03/2006
7Thrombectomy
12/2016 - 04/2004
3Time-to-Treatment
08/2013 - 05/2002
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2022 - 02/2007
1Bioprosthesis
08/2021
1Precision Medicine
11/2020
1Hyperbaric Oxygenation
08/2019
1Surgical Amputation (Amputations)
10/2018
1Transcatheter Aortic Valve Replacement
07/2015
1Thrombolytic Therapy
03/2014
1Catheters
06/2013
1Length of Stay
11/2010
1Anticoagulation Reversal
11/2010
1Contraindications
08/2002